Nivolumab infusion reaction manifesting as plantar erythema and pulmonary infiltrate in a lung cancer patient

Infusion reaction is an adverse event of therapeutic monoclonal antibodies. Nivolumab, an anti‐programmed death‐1 antibody, directly activates T cells, which could probably interact with endothelial cells. The etiology of infusion reaction induced by nivolumab may differ from that of other antibodie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogawara, Daiki, Soda, Hiroshi, Ikehara, Susumu, Sumiyoshi, Makoto, Iwasaki, Keisuke, Okuno, Daisuke, Dohtsu, Yosuke, Taniguchi, Hirokazu, Harada, Tatsuhiko, Fukuda, Yuichi, Mukae, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668487/
https://www.ncbi.nlm.nih.gov/pubmed/28845909
http://dx.doi.org/10.1111/1759-7714.12494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668487/
https://www.ncbi.nlm.nih.gov/pubmed/28845909
http://dx.doi.org/10.1111/1759-7714.12494

Ejemplares similares